Topics / Healthcare Policy

A subject heading for parliamentary questions

Healthcare Policy

999 questions from 121 TDs, between 22 January 2025 and 22 October 2026.

999
questions
990 written, 9 oral
121
TDs have asked
10
parties and groups
Independents counted together
6
departments asked

Questions per month

The record holds no questions for August, when the Dáil does not sit.

Jan 2025Oct 2026
Show as a table
MonthQuestions
January 202512
February 202523
March 202528
April 202522
May 202535
June 202536
July 202534
August 20250
September 202574
October 202524
November 202554
December 202528
January 202650
February 202673
March 202662
April 202691
May 2026147
June 202697
July 202633
August 20260
September 202626
October 202650

Who asks, by party

The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.

  • Aontú25 from 2 TDs · 2 seats today
  • Fianna Fáil199 from 35 TDs · 48 seats today
  • Fine Gael162 from 20 TDs · 38 seats today
  • Green Party6 from 1 TD · 1 seat today
  • Independent42 from 6 TDs · 15 seats today
  • Independent Ireland258 from 3 TDs · 4 seats today
  • Labour Party70 from 10 TDs · 11 seats today
  • People Before Profit-Solidarity30 from 3 TDs · 3 seats today
  • Sinn Féin118 from 30 TDs · 39 seats today

The TDs who asked most

Members of the Government answer questions rather than ask them. Each question counts once.

  1. 247
  2. 51
  3. 39
  4. 38
  5. 31
  6. 25
  7. 20
  8. 17

Asked of

Debated under the same heading

Debates whose official heading is exactly these words.

The questions

Ken O'Flynn Written 9 Jun 2026 · to Health
1814. Deputy Ken O'Flynn asked the Minister for Health whether any national audit, review, inspection, governance assessment, or external evaluation has been undertaken in relation to gender-related healthcare pathways involving minors within the State; and if they will provide details of the findings and recommendations. [41671/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1821. Deputy Ken O'Flynn asked the Minister for Health whether documentary records exist including minutes, memoranda, briefing papers, internal correspondence, emails, governance submissions, or evidential assessments concerning the inclusion of WPATH Standards of Care references within the 2019 CAAC application; and whether such records will be retained under HSE records management and governance procedures. [41688…
Ken O'Flynn Written 9 Jun 2026 · to Health
1839. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has undertaken any modelling of the projected annual eligible population for reimbursement of tirzepatide or semaglutide for obesity treatment over the next five years. [41712/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1840. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the potential annual Exchequer cost associated with reimbursement of obesity pharmacotherapies under current licensing criteria. [41713/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1841. Deputy Ken O'Flynn asked the Minister for Health whether any national eligibility framework, prioritisation framework, or phased access model is under development for obesity pharmacotherapy reimbursement. [41714/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1842. Deputy Ken O'Flynn asked the Minister for Health whether multidisciplinary assessment, psychological screening, or behavioural intervention participation will be mandatory prior to reimbursement approval for obesity pharmacotherapies. [41715/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1843. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken of the long-term fiscal sustainability of reimbursing GLP-1 and dual agonist obesity therapies within the public health system. [41716/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1845. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the projected number of adolescent patients who could potentially meet the proposed reimbursement criteria for semaglutide. [41718/26]
Colm Burke Written 9 Jun 2026 · to Health
1859. Deputy Colm Burke asked the Minister for Health whether she intends to use Ireland’s Presidency of the Council of the EU in 2026 to advance a renewed EU-level political commitment on HIV prevention, building on the legacy of the Dublin Declaration of 2004; and if she will make a statement on the matter. [41766/26]
Colm Burke Written 9 Jun 2026 · to Health
1860. Deputy Colm Burke asked the Minister for Health whether HIV prevention will be considered as part of Ireland’s health priorities during its Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration, particularly in the context of the EU-wide goal of ending HIV as a public health threat by 2030; and if she will make a statement on the matter. [41767/26]
Colm Burke Written 9 Jun 2026 · to Health
1861. Deputy Colm Burke asked the Minister for Health whether Ireland will support the development of a renewed EU HIV/AIDS Action Plan, given that the previous EU action plan lapsed in 2016; and whether this issue will be raised during Ireland’s Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration. [41768/26]
Colm Burke Written 9 Jun 2026 · to Health
1862. Deputy Colm Burke asked the Minister for Health the steps Ireland will take during its Presidency of the Council of the EU to support improved access across Europe to HIV prevention tools, including testing, PrEP, community-led services and stigma-free care; and if she will make a statement on the matter. [41769/26]
Roderic O'Gorman Written 9 Jun 2026 · to Health
1871. Deputy Roderic O'Gorman asked the Minister for Health for a timeline on the skyclarys reimbursement negotiations, following the submission of a proposal by an organisation (details supplied) to the HSE's Corporate Pharmaceutical Unit; and if she will make a statement on the matter. [41813/26]
Duncan Smith Written 9 Jun 2026 · to Health
1872. Deputy Duncan Smith asked the Minister for Health whether she has examined the implications of the Children and Family Relationships Act 2015 for Irish citizens who become parents through lawful assisted reproduction abroad; if she accepts that the current legislation may leave children born in such circumstances without legal protections under Irish law; and if she will make a statement on the matter. [41818/2…
Duncan Smith Written 9 Jun 2026 · to Health
1873. Deputy Duncan Smith asked the Minister for Health the steps being taken to amend the Children and Family Relationships Act 2015 to provide for the recognition in Ireland of intended parents of children born abroad through lawful donor assisted reproduction arrangements, in line with Constitutional equality principles and the best interests of the child; and if she will make a statement on the matter. [41819/26]
Ryan O'Meara Written 9 Jun 2026 · to Health
1875. Deputy Ryan O'Meara asked the Minister for Health for an update on the pricing and reimbursement application for omaveloxolone (skyclarys); if the commercial proposal has been received from the company; and if she will make a statement on the matter. [41821/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1903. Deputy Ken O'Flynn asked the Minister for Health to identify the specific unit, division or named office within her Department responsible for governance oversight of the treatment abroad scheme. [41870/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
1905. Deputy Ken O'Flynn asked the Minister for Health the dates on which the treatment abroad scheme was audited by HSE Internal Audit since 2020; and whether any recommendations were issued following those audits. [41872/26]
John Paul O'Shea Written 9 Jun 2026 · to Health
1942. Deputy John Paul O'Shea asked the Minister for Health for an update on the delivery of the implementation plan in response to the report entitled the Use of Uro-gynaecological Mesh in Surgical Procedure; and if she will make a statement on the matter. [41923/26]
Barry Ward Written 9 Jun 2026 · to Health
1968. Deputy Barry Ward asked the Minister for Health the position regarding the approval process for skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41992/26]
Barry Ward Written 9 Jun 2026 · to Health
1970. Deputy Barry Ward asked the Minister for Health the position regarding the commercial proposal in relation to the approval process for skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41994/26]
Barry Ward Written 9 Jun 2026 · to Health
1971. Deputy Barry Ward asked the Minister for Health the position regarding a timeline for the approval of skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41995/26]
Barry Ward Written 9 Jun 2026 · to Health
1972. Deputy Barry Ward asked the Minister for Health the position regarding meetings held between HSE or Department of Health officials with the manufacturers of skyclarys in relation to its' approval process for the treatment for friedrich's ataxia; and if she will make a statement on the matter. [41996/26]
Ken O'Flynn Written 9 Jun 2026 · to Health
2029. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or Department of Health has engaged with professional regulators, including the Medical Council, Nursing and Midwifery Board of Ireland, CORU, or Dental Council, regarding information-sharing arrangements where registrants are subject to criminal investigation for serious offences; and if she will make a statement on the matter. [42442/26]
Seán Crowe Written 9 Jun 2026 · to Health
2143. Deputy Seán Crowe asked the Minister for Health if the HSE will continue their harm reduction programme of on-site drug analysis and surrender bins at music festivals in 2026. [42959/26]